Prime Movers Lab Fund I LP - 15 Nov 2021 Form 4 Insider Report for Vaxxinity, Inc.

Role: 10%+ Owner
Signature: Prime Movers Lab Fund I LP /s/ Jon Layman, Authorized Person
Issuer symbol: VAXX on OTC
Transactions as of: 15 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 15 Nov 2021, 15:24:42 UTC
Previous filing: 10 Nov 2021
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VAXX	Class A common stock	Conversion of derivative security		+2,294,473			2,294,473	15 Nov 2021	Held by COVAXX PML SPV 1 LP	F1, F2, F7
transaction	VAXX	Class A common stock	Conversion of derivative security		+861,857			861,857	15 Nov 2021	Held by COVAXX PML SPV 2 LP	F1, F3, F7
transaction	VAXX	Class A common stock	Conversion of derivative security		+1,517,754			1,517,754	15 Nov 2021	Held by COVAXX PML SPV 3 LP	F1, F4, F7
transaction	VAXX	Class A common stock	Conversion of derivative security		+3,615,038			3,615,038	15 Nov 2021	Held by Prime Movers Growth Fund 1 LP	F1, F5, F7
transaction	VAXX	Class A common stock	Conversion of derivative security		+9,738,192			9,738,192	15 Nov 2021	Direct	F1, F6, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VAXX	Series A preferred stock	Conversion of derivative security		-3,570,201	-100%		0	15 Nov 2021	Class A common stock	2,294,473		Held by COVAXX PML SPV 1 LP	F1, F2, F7
transaction	VAXX	Series A preferred stock	Conversion of derivative security		-1,341,050	-100%		0	15 Nov 2021	Class A common stock	861,857		Held by COVAXX PML SPV 2 LP	F1, F3, F7
transaction	VAXX	Series A preferred stock	Conversion of derivative security		-2,361,626	-100%		0	15 Nov 2021	Class A common stock	1,517,754		Held by COVAXX PML SPV 3 LP	F1, F4, F7
transaction	VAXX	Series B preferred stock	Conversion of derivative security		-5,625,000	-100%		0	15 Nov 2021	Class A common stock	3,615,038		Held by Prime Movers Growth Fund 1 LP	F1, F5, F7
transaction	VAXX	Series A preferred stock	Conversion of derivative security		-15,152,627	-100%		0	15 Nov 2021	Class A common stock	9,738,192		Direct	F1, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock.
F2	Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
F3	Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F4	Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F5	Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
F6	Held by PML. PML GP I is the general partner of PML.
F7	Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.